Home / Health / Medtronic and Minze Health Collaborate to Advance Bladder Care Across EMEA Region
Medtronic and Minze Health Collaborate to Advance Bladder Care Across EMEA Region
13 Nov
Summary
- Minze Health and Medtronic sign 3-year partnership to market Minze Diary Pod in EMEA
- Diary Pod integrates with Medtronic's InterStim system to support overactive bladder treatment
- Aims to improve diagnosis, treatment initiation, and monitoring of sacral neuromodulation therapy
In a significant development, Minze Health has announced a 3-year partnership with Medtronic to market the Minze Diary Pod, an automated bladder diary solution, across the Europe, Middle East, and Africa (EMEA) region. This collaboration is poised to transform the way individuals with overactive bladder (OAB) and those receiving sacral neuromodulation (SNM) therapy are supported.
The Minze Diary Pod will be integrated into the SNM care pathway, enabling both patients and clinicians to collect and analyze data throughout the diagnosis and follow-up phases. This integration is expected to assist in making timely decisions regarding the initiation of SNM therapy and provide valuable insights into the effectiveness of the treatment following implantation.
Individuals can now monitor their urinary behavior at home using the Minze Diary Pod, eliminating the need for paper records. Healthcare providers, on the other hand, can benefit from automated data interpretation and a secure digital platform for remote oversight and clinical assessment.
Minze Health, a specialist in digital diagnostics and therapeutics in urology, aims to support early diagnosis and personalized care for conditions such as benign prostatic hyperplasia (BPH) and OAB. The company's technology, which holds CE mark and 510(k) exemptions, is now poised to reach a wider audience across the EMEA region through this partnership with Medtronic.
